VTV THERAPEUTICS INC's ticker is VTVT and the CUSIP is 918385105. A total of 25 filers reported holding VTV THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,555 | -42.3% | 30,450 | -20.0% | 0.00% | -100.0% |
Q4 2022 | $25,221 | -18.6% | 38,052 | +17.5% | 0.00% | 0.0% |
Q3 2022 | $31,000 | +138.5% | 32,385 | +82.0% | 0.00% | – |
Q2 2022 | $13,000 | 0.0% | 17,795 | -4.1% | 0.00% | – |
Q1 2022 | $13,000 | -69.8% | 18,559 | -56.9% | 0.00% | -100.0% |
Q4 2021 | $43,000 | +65.4% | 43,108 | +152.3% | 0.00% | +100.0% |
Q3 2021 | $26,000 | -31.6% | 17,087 | -36.1% | 0.00% | – |
Q2 2019 | $38,000 | +192.3% | 26,752 | +57.4% | 0.00% | – |
Q3 2018 | $13,000 | – | 16,995 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 300,000 | $1,491,000 | 0.25% |
SABBY MANAGEMENT, LLC | 117,400 | $583,000 | 0.04% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 39,779 | $198,000 | 0.03% |
Candriam S.C.A. | 140,000 | $696,000 | 0.01% |
Alyeska Investment Group, L.P. | 204,523 | $1,016,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 11,396 | $57,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $373,000 | 0.00% |
FRANKLIN RESOURCES INC | 899,100 | $4,469,000 | 0.00% |
AMERIPRISE FINANCIAL INC | 264,214 | $1,313,000 | 0.00% |
SG Americas Securities, LLC | 12,845 | $64,000 | 0.00% |